These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 37201267

  • 1. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS.
    Webb LM, Cacciaguerra L, Krecke KN, Chen JJ, Sechi E, Redenbaugh V, Dubey D, Pittock SJ, Flanagan EP.
    J Neurol Sci; 2023 Jul 15; 450():120687. PubMed ID: 37201267
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.
    Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, Lopez Chiriboga AS, Sechi E, Hacohen Y, Pittock SJ, Flanagan EP.
    Mult Scler; 2023 Jun 15; 29(7):799-808. PubMed ID: 37218499
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
    Ciotti JR, Eby NS, Brier MR, Wu GF, Chahin S, Cross AH, Naismith RT.
    Mult Scler; 2022 Jan 15; 28(1):49-60. PubMed ID: 33870786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder.
    Luo X, Li H, Xia W, Quan C, ZhangBao J, Tan H, Wang N, Bao Y, Geng D, Li Y, Yang L.
    Eur Radiol; 2024 Jul 15; 34(7):4364-4375. PubMed ID: 38127076
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder.
    Goldman-Yassen A, Lee A, Gombolay G.
    Pediatr Neurol; 2024 Apr 15; 153():125-130. PubMed ID: 38382244
    [Abstract] [Full Text] [Related]

  • 12. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
    Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.
    JAMA Neurol; 2019 Mar 01; 76(3):301-309. PubMed ID: 30575890
    [Abstract] [Full Text] [Related]

  • 13. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
    Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Apostolos Pereira SL, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira À, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C, Tortorella C, Ruggieri S, Amato MP, Ulivelli M, Groppa S, Grothe M, Llufriu S, Sepulveda M, Lukas C, Bellenberg B, Schneider R, Sowa P, Celius EG, Pröbstel AK, Granziera C, Yaldizli Ö, Müller J, Stankoff B, Bodini B, Barkhof F, Ciccarelli O, De Stefano N, MAGNIMS Study Group.
    Ann Neurol; 2024 Aug 01; 96(2):276-288. PubMed ID: 38780377
    [Abstract] [Full Text] [Related]

  • 14. The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis.
    Tan YY, Saffari SE, Tye JSN, Peng X, Koh MJ, Mahmood ABSB, Tan JMM, Tan K, Yeo T.
    Mult Scler Relat Disord; 2024 Sep 01; 89():105775. PubMed ID: 39053396
    [Abstract] [Full Text] [Related]

  • 15. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
    Zhao-Fleming HH, Valencia Sanchez C, Sechi E, Inbarasu J, Wijdicks EF, Pittock SJ, Chen JJ, Wingerchuk DM, Weinshenker BG, Lopez-Chiriboga S, Dubey D, Tillema JM, Toledano M, Yadav H, Flanagan EP.
    Neurology; 2021 Sep 28; 97(13):e1351-e1358. PubMed ID: 34389648
    [Abstract] [Full Text] [Related]

  • 16. Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD.
    Hyun JW, Lee HL, Park J, Kim J, Min JH, Kim BJ, Kim SW, Shin HY, Huh SY, Kim W, Seo JW, Kim KH, Kim SH, Kim HJ.
    Mult Scler; 2022 May 28; 28(6):989-992. PubMed ID: 34865555
    [Abstract] [Full Text] [Related]

  • 17. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR, Kumar A, Singh VK, Prasad R, Pathak A, Chaurasia RN, Mishra VN, Joshi D.
    J Neuroimmunol; 2021 Dec 15; 361():577742. PubMed ID: 34655992
    [Abstract] [Full Text] [Related]

  • 18. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
    Duan Y, Zhuo Z, Li H, Tian DC, Li Y, Yang L, Gao C, Zhang T, Zhang X, Shi FD, Barkhof F, Liu Y.
    J Neurol Neurosurg Psychiatry; 2021 Jul 15; 92(7):709-716. PubMed ID: 33687975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.